Bevacizumab Bevixa is a biosimilar, which means that it is a highly similar version of an existing biologic medicine. Biosimilars are less expensive than the original biologic drugs, but they are still made to the same high standards of quality and safety.
Bevixa (bevacizumab) is given as an injection into a vein. The most common side effects of Bevixa are headache, high blood pressure, fatigue, and protein in the urine. Bevixa can also cause more serious side effects, such as bleeding, infection, and holes in the stomach or intestines.
Bevixa is an important treatment option for people with colorectal, lung, breast, kidney, and ovarian cancer. It can help to shrink tumors, prolong life, and improve quality of life.
Bevixa (bevacizumab) is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor A (VEGF-A), a protein that plays a key role in tumor angiogenesis, the formation of new blood vessels that supply tumors with oxygen and nutrients. By blocking VEGF-A, Bevixa can slow or stop the growth of tumors and help to shrink them.
Here are some of the benefits of Bevixa:
- It is a biosimilar, which means that it is a highly similar version of an existing biologic medicine.
- It is less expensive than the original biologic drug.
- It is still made to the same high standards of quality and safety.
- It can be used to treat a variety of cancers.
- It can be given as an injection into a vein.
Bevixa (bevacizumab) is approved for the treatment of several types of cancer, including:
- Metastatic colorectal cancer
- Non-small cell lung cancer
- Breast cancer
- Ovarian cancer
- Cervical cancer
- Glioblastoma multiforme
Dosage and Administration
Bevixa is administered as an intravenous infusion over 30-90 minutes. The dosage and schedule of administration depend on the type of cancer being treated and the patient’s overall health.
Common Side Effects
The most common side effects of Bevixa are:
- High blood pressure
- Protein in the urine
Serious Side Effects
Bevixa can also cause more serious side effects, including:
- Holes in the stomach or intestines
- Allergic reactions
Q: What is the difference between Bevixa and Avastin?
A: Bevixa is a biosimilar of Avastin. Biosimilars are highly similar versions of existing biologic medicines that have been shown to have no clinically meaningful differences in safety or efficacy compared to the original product. Biosimilars are typically less expensive than the original biologic drugs.
Q: How effective is Bevixa?
A: Bevixa has been shown to be effective in the treatment of several types of cancer. In clinical trials, Bevixa has been shown to improve survival rates, progression-free survival, and overall quality of life for patients with metastatic colorectal cancer, non-small cell lung cancer, breast cancer, ovarian cancer, and cervical cancer.
Q: Who should not take Bevixa?
A: Bevixa should not be taken by patients who have had a severe allergic reaction to bevacizumab or any of the ingredients in Bevixa. Bevixa should also be used with caution in patients with certain medical conditions, such as high blood pressure, bleeding disorders, or a history of blood clots.
Q: How can I get Bevixa?
Bevixa is available by prescription only. If you are interested in learning more about Bevixa, please talk to your doctor.
Bevixa is an important treatment option for patients with several types of cancer. It can help to shrink tumors, prolong life, and improve quality of life. If you are considering Bevixa as a treatment option, please discuss the risks and benefits with your doctor.